15. What does it mean if my report also mentions “atypical ductal hyperplasia (ADH)” or “atypical lobular hyperplasia (ALH)”?
These are precursors to ductal carcinoma in-situ and lobular carcinoma in-situ, respectively. These typically are of no importance when seen on needle biopsy or excision if there is in-situ cancer elsewhere on the sampling. 16. What does it mean if my report also says any of the following terms: “usual duct hyperplasia”, “adenosis”, “sclerosing adenosis”, “radial scar”, “complex sclerosing lesion”, “papillomatosis”, “papilloma”, “apocrine metaplasia”, “cysts”, “columnar cell change”, “collagenous spherulosis”, “duct ectasia”, “fibrocystic changes”, “flat epithelial atypia”, or “columnar cell change with prominent apical snouts and secretions (CAPSS)”?
Related Questions
- What does it mean if my report on ductal carcinoma in-situ (DCIS) mentions "estrogen receptor (ER)" or "progesterone receptor (PR)"?
- What does it mean if my report mentions "estrogen receptor (ER)" or "progesterone receptor (PR)"?
- 17. What does it mean if my report mentions "microcalcifications" or "calcifications"?